The present study is aimed at investigating the serum levels of miRNA-101, -103, and -29a in GC patients, their correlation with clinicopathological characteristics, and ATX and LPA2 expression; it may help to find a new strategy in the diagnosis and treatment of GC patients. Here, LPAR2 is linked to gastric cancer.